Skin care trends
This article was originally published in The Rose Sheet
Executive Summary
Traditional skin care marketers are attempting to compete with dermatologist-developed skin care brands such as Dr. Perricone and Dr. Brandt by offering products with therapeutic, high-end positioning, market research firm Kline & Co. concludes in skin care study to be published this fall. Products pursuing that approach include Avon Clinical and P&G's Olay Regenerist, which are touted as advanced anti-aging offerings. Prestige marketers such as Estee Lauder also are offering more clinically-positioned skin care treatments. Lauder recently purchased dermatologist-developed Rodan & Field's skin care line, while firm's Prescriptives brand relies on spokesperson Dr. Karen Grossman to promote its Dermapolish at-home microdermabrasion system (1"The Rose Sheet" July 21, 2003, p. 9)...
You may also be interested in...
Lauder Rodan & Fields Buy Adds Dermatological Brand To Skin Care Portfolio
Estee Lauder is moving into the dermatological skin care category with the acquisition of Rodan & Fields, a product line developed by dermatologists and sold in selective high-end department stores
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.